AMGN Amgen, Inc.
$465.23
Amgen, Inc. (AMGN) is expected to report earnings on February 2, 2027, after the market close. The consensus earnings estimate is $5.55 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -3.0% since its last earnings release on November 3, 2026.
Amgen Beat Expectations, Raises Guidance In-line with Estimates
Tuesday, November 3, 2026 · 4:01 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 2
Tuesday · 4:00 PM ET
Earnings Whisper
-
vs $5.55
Rev est $10.29B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$467.75
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Amgen, Inc.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Sector
Healthcare
Industry
Biotechnology
Held By 10 ETFs, by dollar flow
- QQQ Invesco QQQ Trust
- OEF iShares S&P 100 ETF
- QTOP iShares Nasdaq Top 30 Stocks ETF
- DIA SPDR Dow Jones Industrial Average ETF
- IYH iShares U.S. Healthcare ETF
- HDV iShares Core High Dividend ETF
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- BBH VanEck Biotech ETF
Charts powered in part by Lightweight Charts™ by TradingView.